Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin vs Metformin on Body Composition in Elderly Type 2 Diabetes
NCT07323381Phase 4Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of henagliflozin in type 2 diabetes mellitus (T2DM) (2 arms). Primary endpoint: Appendicular Skeletal Muscle Index at 24 weeks. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07323381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323381.